Adverse Events During Immunotherapy Against Grass Pollen‐Induced Allergic Rhinitis – Differences Between Subcutaneous and Sublingual Treatment

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 73-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study

By Berto Patrizia   Frati Franco   Incorvaia Cristoforo   Cadario Gianni   Contiguglia Rosario   Di Gioacchino Mario   Puccinelli Paola   Senna Gian Enrico   Valle Carla  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 261-266

Informa Healthcare

Access to resources Recommend Favorite

Lack of Detectable Alterations in Immune Responses during Sublingual Immunotherapy in Children with Seasonal Allergic Rhinoconjunctivitis to Grass Pollen

By  

International Archives of Allergy and Immunology, Vol. 136, Iss. 2, 2005-02 ,pp. : 134-141

Karger

Access to resources Recommend Favorite

Safety of sublingual immunotherapy started during the pollen season

By Ariano Renato   Incorvaia Cristoforo   La Grutta Stefania   Marcucci Francesco   Pajno Giovanbattista   Sensi Laura   Di Cara Giuseppe   Sieber Jochen   Yacoub Mona-Rita   Frati Franco  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 103-107

Informa Healthcare

Access to resources Recommend Favorite

Sublingual immunotherapy with natural grass pollen extracts: an appraisal of the evidence

By Di Bona Danilo   Leto-Barone Maria Stefania   La Piana Simona   Di Lorenzo Gabriele  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 443-454

Future Medicine

Access to resources Recommend Favorite